We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+14.34%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$546M
AUM Growth
+$146M
(+36%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
17.28%
Top 10 Holdings %
Top 10 Hldgs %
77.86%
Holding
148
New
66
Increased
27
Reduced
14
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGU
Agrium
AGU
|
+$5.04M |
| 2 |
Dover
DOV
|
+$4.81M |
| 3 |
FedEx
FDX
|
+$4.81M |
| 4 |
Celanese
CE
|
+$4.28M |
| 5 |
Bunge Global
BG
|
+$3.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CADE
Cadence Bank
CADE
|
+$2.17M |
| 2 |
Huntington Bancshares
HBAN
|
+$2.12M |
| 3 |
Edwards Lifesciences
EW
|
+$1.82M |
| 4 |
M&T Bank
MTB
|
+$1.72M |
| 5 |
Biogen
BIIB
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 9.04% |
| 2 | Financials | 8% |
| 3 | Healthcare | 4.75% |
| 4 | Materials | 3.56% |
| 5 | Technology | 1.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBI
76
DELISTED
Chicago Bridge & Iron Nv
CBI
| $626K | 0.11% |
+20,350
| New | +$657K |
|
77
Jacobs Solutions
J
$15.9B
| $623K | 0.11% |
+13,631
| New | +$645K |
|
78
Fluor
FLR
$7.01B
| $621K | 0.11% |
+11,800
| New | +$644K |
|
|
DERM
79
DELISTED
Dermira, Inc.
DERM
| $620K | 0.11% |
18,180
-2,949
| -14% | -$95.1K |
|
|
ULTI
80
DELISTED
Ultimate Software Group Inc
ULTI
| $611K | 0.11% |
3,130
+1,687
| +117% | +$328K |
|
81
Pfizer
PFE
$143B
| $607K | 0.11% |
+18,709
| New | +$590K |
|
82
UMB Financial
UMBF
$11.1B
| $602K | 0.11% |
+8,000
| New | +$612K |
|
|
ALDR
83
DELISTED
Alder Biopharmaceuticals
ALDR
| $530K | 0.1% |
+25,500
| New | +$565K |
|
|
RVNC
84
DELISTED
Revance Therapeutics, Inc.
RVNC
| $520K | 0.1% |
+25,000
| New | +$514K |
|
|
EPZM
85
DELISTED
Epizyme, Inc
EPZM
| $492K | 0.09% |
+28,700
| New | +$382K |
|
|
TTPH
86
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $489K | 0.09% |
+2,663
| New | +$299K |
|
87
Puma Biotechnology
PBYI
$404M
| $480K | 0.09% |
+12,900
| New | +$471K |
|
|
NDRM
88
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $478K | 0.09% |
+18,000
| New | +$446K |
|
|
ARRY
89
DELISTED
Array Biopharma Inc
ARRY
| $472K | 0.09% |
+52,800
| New | +$562K |
|
90
BOK Financial
BOKF
$8.58B
| $470K | 0.09% |
+6,000
| New | +$489K |
|
91
ServiceNow
NOW
$115B
| $458K | 0.08% |
+26,165
| New | +$456K |
|
92
Monolithic Power Systems
MPWR
$70.1B
| $450K | 0.08% |
+4,890
| New | +$433K |
|
|
SBNY
93
DELISTED
Signature Bank
SBNY
| $445K | 0.08% |
3,000
| – | – |
|
94
EPAM Systems
EPAM
$5.51B
| $444K | 0.08% |
+5,876
| New | +$409K |
|
|
WMGI
95
DELISTED
Wright Medical Group Inc
WMGI
| $442K | 0.08% |
14,200
-9,136
| -39% | -$248K |
|
96
Sensata Technologies
ST
$6.74B
| $435K | 0.08% |
+9,952
| New | +$417K |
|
97
Meta Platforms (Facebook)
META
$1.42T
| $432K | 0.08% |
3,041
-1,153
| -27% | -$154K |
|
98
Expedia Group
EXPE
$35.4B
| $397K | 0.07% |
+3,143
| New | +$384K |
|
|
ELOS
99
DELISTED
Syneron Medical Ltd
ELOS
| $391K | 0.07% |
37,087
-44,664
| -55% | -$432K |
|
100
Bruker
BRKR
$9.57B
| $374K | 0.07% |
+16,021
| New | +$376K |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2017 Portfolio in Review
As of Q1 2017, Crestline Management held 148 positions worth $546M, up 36% from $401M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Crestline Management deployed $94.4M of net new capital in Q1 2017, opening 66 new positions and adding to 27 existing holdings. Its largest new stake was Agrium: 50,000 shares worth $4.78M.
By sector, the portfolio is most concentrated in Industrials at 9% of assets, up from 2.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $1.25M trimmed.
- Crestline Management's largest Q1 2017 buy was Agrium: 50,000 shares worth $4.78M.
- Crestline Management added most to US Bancorp in Q1 2017, an estimated $2.67M increase.
- Crestline Management's biggest Q1 2017 reduction was Zimmer Biomet, cutting an estimated $1.25M.
- Crestline Management fully exited Cadence Bank in Q1 2017, selling an estimated $2.17M.
- Crestline Management's ten largest holdings make up 78% of its $546M portfolio in Q1 2017.
- Crestline Management opened 66 new positions and closed 36 in Q1 2017.
- Crestline Management's portfolio value rose 36% quarter-over-quarter to $546M.
Based on Crestline Management's 13F filing for Q1 2017, filed 12 May 2017.